Non Small Cell Lung Cancer Genetic Testing

Mutations in epidermal growth factor receptor egfr kras and anaplastic lymphoma kinase alk are mutually exclusiv.
Non small cell lung cancer genetic testing. These tests are performed by a pathologist. Egfr testing and erlotinib use in non small cell lung cancer patients in kentucky plos one 2020. Lung cancer is a disease in which certain cells in the lungs become abnormal and multiply uncontrollably to form a tumor. Personalized medicine involves looking at the cells obtained from a biopsy to see if there are any genetic mutations changes in your genes that could be linked to the type of cancer you have.
10 1371 journal pone 0237790 journal information. Gene tests can also help your doctor find the right treatment for you if you do get lung cancer. Lung cancer may not cause signs or symptoms in its early stages. While identifying new genetic targets and developing novel drugs is important for the future of non small cell lung cancer nsclc more emphasis should be put on improving patient access to existing targeted.
Some people with lung cancer have chest pain frequent coughing blood in the mucus breathing problems trouble swallowing or speaking loss of appetite and weight loss fatigue or swelling in the face or neck. In recent years personalized medicine has begun to bring new hope to people with lung cancer especially non small cell lung cancer. About 10 of people with non small cell lung cancer nsclc have a mutation in the egfr gene and. For example tumors in approximately 60 percent of patients.